CV Sciences, Inc. (CVSI)
OTCMKTS
· Delayed Price · Currency is USD
0.0451
-0.0001 (-0.22%)
Sep 24, 2024, 2:37 PM EDT
CV Sciences Revenue
CV Sciences had revenue of $3.95M in the quarter ending June 30, 2024, a decrease of -0.30%. This brings the company's revenue in the last twelve months to $15.85M, up 0.71% year-over-year. In the year 2023, CV Sciences had annual revenue of $16.00M, down -1.24%.
Revenue (ttm)
15.85M
Revenue Growth
+0.71%
P/S Ratio
0.48
Revenue / Employee
368.51K
Employees
43
Market Cap
8.64M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 16.00M | -201.00K | -1.24% |
Dec 31, 2022 | 16.21M | -3.84M | -19.17% |
Dec 31, 2021 | 20.05M | -4.38M | -17.93% |
Dec 31, 2020 | 24.43M | -29.27M | -54.50% |
Dec 31, 2019 | 53.70M | 5.45M | 11.30% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Medexus Pharmaceuticals Inc. | 108.78M |
CV Sciences News
- 4 weeks ago - CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements - PRNewsWire
- 4 weeks ago - Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024 - Benzinga
- 6 weeks ago - CV Sciences, Inc. (CVSI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - CV Sciences, Inc. Reports Second Quarter 2024 Financial Results - PRNewsWire
- 7 weeks ago - CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024 - PRNewsWire
- 4 months ago - CV Sciences, Inc. (CVSI) Q1 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - CV Sciences, Inc. Reports First Quarter 2024 Financial Results - PRNewsWire
- 4 months ago - CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER - PRNewsWire